ArticleClinical epigenetics2023

A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.

Sara Mongiorgi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.